GPC3 CAR-T therapy (Hrain Biotechnology) | Interleukin Related interleukin-related.com

Product Name :
GPC3 CAR-T therapy (Hrain Biotechnology)

Search keywords :
Glypican 3

drugId :
null

Target Vo:
Glypican-3

Target Vo Short Name :
GPC3

Moa_Name:
Glypican-3 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Hrain Biotechnology Co Ltd

Active Company_Name :
Xinqiao Hospital, Army Medical University

Active Indication_Name:
Carcinoma, Hepatocellular

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-JNK (Thr183) Antibody
eIF4B Antibody
6X His-tag (C-terminal) Antibody (YA860): Anti-6X His-tag (C-terminal) Antibody is a non-conjugated and Mouse origined monoclonal antibody. It can be used for WB,IP assays in the background of .

Author: Interleukin Related

Related Posts